OctoPlus/Sanofi inks master service agreement

OctoPlus has signed a master service agreement with Sanofi, following a successful collaboration in ongoing development of a number of formulations, which has made and will make a material contribution to OctoPlus' 2012 and 2013 revenues. Further details on the compound and activities were not disclosed.

This article is tagged to:
Sector: Medical Devices
Geography: Netherlands, France

Access all of our latest analysis, data and forecasts - request a trial